Wellgistics Health Inc ( (WGRX) ) just unveiled an update.
On February 25, 2025, Wellgistics Health, Inc. entered into a consulting agreement with Hudson Global Ventures, LLC to receive business advisory services for a fee and shares. The following day, Wellgistics announced an agreement with Tollo Health, LLC to market Tollo’s medical food products for GLP-1 treatment-related side effects and Long COVID, aiming to expand its healthcare ecosystem and address unmet needs in these markets. This strategic move positions Wellgistics as a key supplier in the growing GLP-1 and Long COVID markets, potentially enhancing its industry standing and offering new solutions for patients and healthcare providers.
More about Wellgistics Health Inc
Wellgistics Health, Inc. is a holding company focused on healthcare technology and pharmaceutical services, aiming to create a micro health ecosystem with a portfolio that includes a technology platform, pharmacy, and wholesale operations. The company is dedicated to improving patient care through integrated solutions for pharmacies, providers, pharmaceutical manufacturers, and payors, and its subsidiary, Wellgistics LLC, focuses on wholesale operations and pharmaceutical distribution.
YTD Price Performance: -22.05%
Average Trading Volume: 185,071
See more data about WGRX stock on TipRanks’ Stock Analysis page.